TD Asset Management
BRLI

TD Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

TD Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,374
Closed -$222K – 1446
2015
Q1 		$222K Sell
6,374
-5,734
-47% -$194K ﹤0.01% 1320
2014
Q4 		$389K Buy
+12,108
New +$350K ﹤0.01% 1165
2014
Q3 		– Sell
-8,967
Closed -$271K – 1368
2014
Q2 		$271K Hold
8,967
– – ﹤0.01% 1161
2014
Q1 		$248K Buy
8,967
+5
+0.1% +$131 ﹤0.01% 1198
2013
Q4 		$229K Hold
8,962
– – ﹤0.01% 1200
2013
Q3 		$268K Buy
+8,962
New +$249K ﹤0.01% 1142

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

TD Asset Management's BRLI Position: Q2 2015 in Review

TD Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 6,374 shares — an estimated $222K sold.

TD Asset Management first reported a position in BRLI in Q3 2013 and held it in 6 quarters. The position peaked at $389K in Q4 2014. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • TD Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • TD Asset Management sold 6,374 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $222K.
  • TD Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2013 and held it in 6 quarters.
  • TD Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $389K in Q4 2014.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on TD Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.